Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-09

Clinical Trial Update: Concentrations of Voriconazole in Blood and BAL-fluid After Inhalation and Oral Administration [NA]

View source ↗

Summary

The trial compared concentrations of voriconazole in blood and bronchoalveolar lavage fluid after inhaled versus oral administration in invasive aspergillosis, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VFEND (Voriconazole)

Snippet

Sponsor: University of Aarhus | Conditions: Invasive Aspergillosis | NA | Status: TERMINATED